These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24296047)

  • 21. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
    Schwameis R; Fille M; Manafi M; Zeitlinger M; Sauermann R
    Res Microbiol; 2012 Apr; 163(3):157-60. PubMed ID: 22210435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of ethylene-oxy spacer group on the activity of linezolid: synthesis of potent antibacterials possessing a thiocarbonyl group.
    Selvakumar N; Raheem MA; Khera MK; Rajale TV; Kumar MS; Kandepu S; Das J; Rajagopalan R; Iqbal J; Trehan S
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4169-72. PubMed ID: 14622995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel tricyclic oxazolidinones by a tandem SN2 and SNAr reaction: SAR studies on conformationally constrained analogues of Linezolid.
    Selvakumar N; Yadi Reddy B; Sunil Kumar G; Khera MK; Srinivas D; Sitaram Kumar M; Das J; Iqbal J; Trehan S
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4416-9. PubMed ID: 16781153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of linezolid resistance in Staphylococcus epidermidis: first reported linezolid resistant coagulase negative staphylococcus in Turkey.
    Yalçin B; Selek MB; Bektöre B; Hoşbul T; Özyurt M
    Turk J Med Sci; 2014; 44(6):1136-8. PubMed ID: 25552175
    [No Abstract]   [Full Text] [Related]  

  • 25. [Linezolid].
    Yanagihara K; Yanagihara K; Kohno S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():352-9. PubMed ID: 17455645
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
    Ross JE; Anderegg TR; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 May; 52(1):53-8. PubMed ID: 15878443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antibacterial activities of N-substituted-glycinyl 1H-1,2,3-triazolyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Eur J Med Chem; 2013 Aug; 66():246-57. PubMed ID: 23811087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant.
    Sierra JM; Ortega M; Tarragó C; Albet C; Vila J; Terencio J; Guglietta A
    J Antimicrob Chemother; 2009 Nov; 64(5):990-2. PubMed ID: 19717395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
    Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents.
    Khera MK; Cliffe IA; Mathur T; Prakash O
    Bioorg Med Chem Lett; 2011 May; 21(10):2887-9. PubMed ID: 21507643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics.
    Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6179-83. PubMed ID: 18951792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
    Sztanke K; Pasternak K; Sztanke M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of linezolid on staphylococcal adherence versus time of treatment.
    Pagano PJ; Buchanan LV; Dailey CF; Haas JV; Van Enk RA; Gibson JK
    Int J Antimicrob Agents; 2004 Mar; 23(3):226-34. PubMed ID: 15164962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
    Mendes RE; Hogan PA; Streit JM; Jones RN; Flamm RK
    J Antimicrob Chemother; 2014 Jun; 69(6):1582-8. PubMed ID: 24468866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
    Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
    New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates.
    Tato M; de la Pedrosa EG; Cantón R; Gómez-García I; Fortún J; Martín-Davila P; Baquero F; Gomez-Mampaso E
    Int J Antimicrob Agents; 2006 Jul; 28(1):75-8. PubMed ID: 16774814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of an infectious diseases specialist-directed computerized physician order entry antimicrobial stewardship program targeting linezolid use.
    Po JL; Nguyen BQ; Carling PC
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):434-5. PubMed ID: 22418647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.